9 December 2021

Biologics Scleroderma

Promising findings for PsA treatments

10 November 2021

Scleroderma

Day 4 conference highlights

4 November 2021

Pharmacy Guild of Australia Scleroderma

ACR Convergence 2021 preview

4 November 2021

Biologics Pregnancy Scleroderma Women

PsA patients and pregnancy risks

14 October 2021

Scleroderma

Oral treatments most favoured by PsA patients

2 September 2021

Analgesics Conditions Scleroderma

New hub for patients living with psoriatic arthritis

22 July 2021

Scleroderma Systemic vasculitis

Pregnancy in PsA: outcomes review

15 July 2021

Scleroderma

Biologics vs phototherapy in psoriasis

1 July 2021

Ankylosing Spondylitis Biologics PBS Scleroderma

Guselkumab now PBS-listed for psoriatic arthritis

3 June 2021 SPONSORED

Scleroderma

Treating psoriatic arthritis during pregnancy and breastfeeding

3 June 2021

Corticosteroids Scleroderma Spondyloarthritis

Top 10 posters @ ARA ASM

19 May 2021

Scleroderma

FMT falls flat in first PsA trial

6 May 2021

EULAR Mental Health Reactive Arthritis Scleroderma Spondyloarthritis

Treat depression and anxiety for better PsA outcomes

29 April 2021

Ankylosing Spondylitis Biologics Scleroderma

Bimekizumab takes on all-comers in psoriasis – and wins

25 March 2021

Ankylosing Spondylitis Biologics Conditions Scleroderma

Considering Taltz withdrawal in PsA patients?

27 January 2021

O&G Scleroderma Spondyloarthritis

MyRA enters next phase of RA community support